Annual Meeting Highlights

2016 ASCO Meeting Highlights in Pancreatic Cancer
2016 ASCO Meeting Highlights in Pancreatic Cancer
CME, CPE
Kate O'Rourke
Release Date: June 30, 2016
Expiration Date: June 30, 2017
This activity will describe five exciting and clinically meaningful studies in pancreatic cancer that were presented at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois. Participants will have the opportunity to review summaries of the clinical data, including commentary from investigators and authors, regarding the significance of the data and its impact on practice. The presentations address immuno-oncology, new agents, and novel combination therapies in both the first-line and advanced/metastatic setting for patients with pancreatic cancer.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Celgene Corporation
Begin, Earn CreditView Only, No Credit
 

Partners in Pancreatic Cancer would like to recognize and thank Celgene Corporation
for their educational support of PartnersinPancreaticCancer.com.

©2017 MediCom Worldwide, Inc. All rights reserved